Nuclear Medicine and Biology
Volume 35, Issue 1 , Pages 43-52 , January 2008

(R)-N-Methyl-3-(3-125I-pyridin-2-yloxy)-3-phenylpropan-1-amine: a novel probe for norepinephrine transporters

  • Balagopal Lakshmi

      Affiliations

    • Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA
    • ,
  • Mei-Ping Kung

      Affiliations

    • Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA
    • ,
  • Brian Lieberman

      Affiliations

    • Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA
    • ,
  • Jun Zhao

      Affiliations

    • Department of Psychiatry, Columbia University, New York City, NY 10032, USA
    • ,
  • Rikki Waterhouse

      Affiliations

    • Department of Psychiatry, Columbia University, New York City, NY 10032, USA
    • ,
  • Hank F. Kung

      Affiliations

    • Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA
    • Department of Pharmacology, University of Pennsylvania, Philadelphia, PA 19104, USA
    • Corresponding Author InformationCorresponding author. Department of Radiology University of Pennsylvania, Philadelphia, PA 19104, USA. Tel.: +1 215 662 3096; fax: +1 215 349 5035.

Received 27 April 2007 ,Revised 20 July 2007 ,Accepted 30 August 2007.

References 

  1. Amara SG, Kuhar MJ. Neurotransmitter transporters: recent progress. Annu Rev Neurosci. 1993;16:73–93
  2. Blakely RD, Bauman AL. Biogenic amine transporters: regulation in flux. Curr Opin Neurobiol. 2000;10:328–336
  3. Zhu M-Y, Ordway GA. Down-regulation of norepinephrine transporters on PC12 cells by transporter inhibitors. J Neurochem. 1997;68:134–141
  4. Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, et al. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci. 1997;17:8451–8458
  5. Biederman J, Spencer T. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry. 1999;46:1234–1242
  6. Viggiano D, Ruocco LA, Arcieri S, Sadile AG. Involvement of norepinephrine in the control of activity and attentive processes in animal models of Attention Deficit Hyperactivity Disorder. Neural Plast. 2004;11:133–149
  7. Tejani-Butt SM, Yang J, Zaffar H. Norepinephrine transporter sites are decreased in the locus coeruleus in Alzheimer's disease. Brain Res. 1993;631:147–150
  8. Kung MP, Choi SR, Hou C, Zhuang ZP, Foulon C, Kung HF. Selective binding of 2-[125I]iodo-nisoxetine to norepinephrine transporters in the brain. Nucl Med Biol. 2004;31:533–541
  9. Wilson AA, Patrick Johnson D, Mozley D, Hussey D, Ginovart N, Nobrega J, et al. Synthesis and in vivo evaluation of novel radiotracers for the in vivo imaging of the norepinephrine transporter. Nucl Med Biol. 2003;30:85–92
  10. Schou M, Halldin C, Sovago J, Pike VW, Gulyas B, Mozley PD, et al. Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[(11)C]MeNER. Nucl Med Biol. 2003;30:707–714
  11. Ding YS, Lin KS, Garza V, Carter P, Alexoff D, Logan J, et al. Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs. Synapse. 2003;50:345–352
  12. Haka M, Kilbourn M. Synthesis and regional mouse brain distribution of [11C]-nisoxetine, a norepinephrine uptake inhibitor. Nucl Med Biol. 1989;16:771–774
  13. Ding Y-S, Lin K-S, Logan J, Benveniste H, Carter P. Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine. J Neurochem. 2005;94:337–351
  14. Schou M, Pike VW, Varrone A, Gulyas B, Farde L, Halldin C. Synthesis and PET evaluation of (R)-[S-methyl-11C]thionisoxetine, a candidate radioligand for imaging brain norepinephrine transporters. J Labelled Compd Radiopharm. 2006;49:1007–1019
  15. Schou M, Pike VW, Sovago J, Gulyas B, Gallagher PT, Dobson DR, et al. Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET. Bioorg Med Chem. 2007;15:616–625
  16. Schou M, Halldin C, Sovago J, Pike VW, Hall H, Gulyas B, et al. PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain. Synapse. 2004;53:57–67
  17. Lin KS, Ding YS, Kim SW, Kil KE. Synthesis, enantiomeric resolution, F-18 labeling and biodistribution of reboxetine analogs: promising radioligands for imaging the norepinephrine transporter with positron emission tomography. Nucl Med Biol. 2005;32:415–422
  18. Ding Y-S, Lin K-S, Logan J. PET imaging of norepinephrine transporters. Curr Pharm Des. 2006;12:3831–3845
  19. Kiyono Y, Kanegawa N, Kawashima H, Fujiwara H, Iida Y, Nishimura H, et al. A new norepinephrine transporter imaging agent for cardiac sympathetic nervous function imaging: radioiodinated (R)-N-methyl-3-(2-iodophenoxy)-3-phenylpropanamine. Nucl Med Biol. 2003;30:697–706
  20. Kiyono Y, Kanegawa N, Kawashima H, Kitamura Y, Iida Y, Saji H. Evaluation of radioiodinated (R)-N-methyl-3-(2-iodophenoxy)-3-phenylpropanamine as a ligand for brain norepinephrine transporter imaging. Nucl Med Biol. 2004;31:147–153
  21. Chumpradit S, Kung M-P, Panyachotipun C, Prapansiri V, Foulon C, Brooks BP, et al. Iodinated tomoxetine derivatives as selective ligands for serotonin and norepinephrine uptake sites. J Med Chem. 1992;35:4492–4497
  22. Kanegawa N, Kiyono Y, Kimura H, Sugita T, Kajiyama S, Kawashima H, et al. Synthesis and evaluation of radioiodinated (S,S)-2-(alpha-(2-iodophenoxy)benzyl)morpholine for imaging brain norepinephrine transporter. Eur J Nucl Med Mol Imaging. 2006;33:639–647
  23. Tamagnan GD, Brenner E, Alagille D, Staley JK, Haile C, Koren A, et al. Development of SPECT imaging agents for the norepinephrine transporters: [123I]INER. Bioorg Med Chem Lett. 2007;17:533–537
  24. Kung MP, Hou C, Zhuang Z-P, Zhang B, Skovronsky DM, Gur T, et al. IMPY: an improved thioflavin-T derivative for in vivo labeling of β-amyloid plaques. Brain Res. 2002;956:202–210
  25. Kung MP, Hou C, Oya S, Mu M, Acton PD, Kung HF. Characterization of [123I]IDAM as a novel single-photon emission tomography tracer for serotonin transporters. Eur J Nucl Med. 1999;26:844–853
  26. Kung M-P, Essman WD, Frederick D, Meegalla S, Goodman M, Mu M, et al. IPT: a novel iodinated ligand for the CNS dopamine transporter. Synapse. 1995;20:316–324
  27. Gu H, Wall SC, Rudnick G. Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J Biol Chem. 1994;269:7124–7130
  28. Munson PJ, Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980;107:220–239
  29. Robertson DW, Krushinski JH, Fuller RW, Leander JD. Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor. J Med Chem. 1988;1412–1417
  30. Mitsunobu O. The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products. Synthesis. 1981;1–25
  31. Bastiaans HMM, van der Baan JL, Ottenheijm HCJ. Flexible and convergent total synthesis of cyclotheonamide B. J Org Chem. 1997;62:3880–3889
  32. Lindstroem S, Ripa L, Hallberg A. Synthesis of two conformationally constrained analogues of the minor tobacco alkaloid anabasine. Org Lett. 2000;2:2291–2293
  33. Oya S, Choi SR, Kung MP, Kung HF. 5-Chloro-2-(2′-((dimethylamino)methyl)-4′-iodophenylthio)benzenamine: a new serotonin transporter ligand. Nucl Med Biol. 2007;34:129–139
  34. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego, CA: New York Academic Press; 1986;
  35. Cortes R, Soriano E, Pazos A, Probst A, Palacios JM. Autoradiography of antidepressant binding sites in the human brain: localization using [3H]paroxetine. Neuroscience. 1988;27:473–496
  36. De Souza EB, Kuyatt BL. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain. Synapse. 1987;1:488–496
  37. Kovachich GB, Aronson CE, Brunswick DJ, Frazer A. Quantitative autoradiography of serotonin uptake sites in rat brain using [3H]cyanoimipramine. Brain Res. 1988;454:78–88
  38. Biegon A, Mathis CA, Hanrahan SM, Jagust WJ. [125I]5-Iodo-6-nitroquipazine: a potent and selective ligand for the 5-hydroxytryptamine uptake complex II in vivo studies in rats. Brain Res. 1993;619:236–246

PII: S0969-8051(07)00224-7

doi: 10.1016/j.nucmedbio.2007.08.007

Nuclear Medicine and Biology
Volume 35, Issue 1 , Pages 43-52 , January 2008

Article Tools

* Image Usage & Resolution